Latest news
This Week’s CGT News: In Vivo CAR T Draws Major Investment - The Medicine MakerThe Medicine Maker · Mon, 10 Aug 2026 10:12:24 GMTResearchers Discover Immune ‘Off Switch’ Used By Cancer Cells - South Florida ReporterSouth Florida Reporter · Mon, 10 Aug 2026 05:02:17 GMTDoes Patient Selection Inflate CAR T Outcomes in Multiple Myeloma? - CancerNetworkCancerNetwork · Sun, 09 Aug 2026 16:10:02 GMTLow Dose CAR T Therapy Achieved High Remission Rates - EMJEMJ · Sun, 09 Aug 2026 15:03:11 GMTRiboX’s Circular RNA CAR-T IND Clearance Forces the Industry to Rethink Everything It Knows About Cell Therapy Trial Design - The Clinical Trial VanguardThe Clinical Trial Vanguard · Sun, 09 Aug 2026 07:28:07 GMTScience Fiction Made Real: Kerry Rogers, MD, on How CAR T Works - The American Journal of Managed CareThe American Journal of Managed Care · Sat, 08 Aug 2026 12:27:00 GMTWhat Makes an Optimal CAR T-Cell Therapy Candidate in Multiple Myeloma - CancerNetworkCancerNetwork · Fri, 07 Aug 2026 22:04:53 GMTWhy CAR T-Cell Therapy Should Precede Bispecifics in Multiple Myeloma - CancerNetworkCancerNetwork · Fri, 07 Aug 2026 15:09:51 GMT